Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Health Care · Pharmaceuticals · BD
Tk18.80
-6.93% today · +19.7% 1Y
Silco Pharmaceuticals Limited (DSE: SILCOPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.95M.
Over the last twelve months the share price has gained 19.7%, trading between 11.10 and 23.30.
Tweenvest scores Silco Pharmaceuticals Limited across four factors: quality 76/100, value 26/100, growth 0/100, dividend 23/100. Its strongest factor is quality.
SILCOPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.95M
- Revenue (TTM)
- $3.33M
- P/E
- 56.82
- EPS
- 0.33
- Dividend yield
- 0.59%
- Beta (5Y)
- 0.35
- 52-week high
- Tk23.30
- 52-week low
- Tk11.10
- Avg volume (3M)
- —
- Shares outstanding
- 103.81M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,199.54 | -2.77% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.17 | -1.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.46 | -0.40% |
Figures last refreshed Aug 18, 2026.